Blend Labs (NYSE:BLND – Get Free Report) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Monday,Zacks.com reports.
Other equities analysts have also recently issued research reports about the stock. Keefe, Bruyette & Woods dropped their target price on shares of Blend Labs from $2.25 to $1.90 and set a “market perform” rating on the stock in a research report on Friday, May 8th. Weiss Ratings lowered Blend Labs from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, June 2nd. Citigroup reaffirmed an “outperform” rating on shares of Blend Labs in a research report on Friday, May 8th. Citizens Jmp dropped their price target on Blend Labs from $5.00 to $4.00 and set a “market outperform” rating on the stock in a report on Friday, May 8th. Finally, Canaccord Genuity Group cut their price objective on Blend Labs from $5.25 to $4.50 and set a “buy” rating on the stock in a research report on Friday, May 15th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Blend Labs currently has an average rating of “Hold” and a consensus target price of $3.32.
Blend Labs Stock Performance
Institutional Investors Weigh In On Blend Labs
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Capricorn Fund Managers Ltd bought a new stake in shares of Blend Labs in the first quarter valued at approximately $11,049,000. Irenic Capital Management LP purchased a new position in Blend Labs in the 4th quarter valued at approximately $9,469,000. Park West Asset Management LLC purchased a new position in Blend Labs in the 3rd quarter valued at approximately $6,205,000. Potrero Capital Research LLC purchased a new position in Blend Labs in the 4th quarter valued at approximately $5,050,000. Finally, Marshall Wace LLP raised its holdings in Blend Labs by 157.6% during the 2nd quarter. Marshall Wace LLP now owns 2,522,141 shares of the company’s stock valued at $8,323,000 after acquiring an additional 1,543,220 shares during the period. 52.56% of the stock is currently owned by institutional investors.
About Blend Labs
Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend’s platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.
The company’s product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.
Recommended Stories
- Five stocks we like better than Blend Labs
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.
